Literature DB >> 27168039

[Diagnosis and treatment of retroperitoneal fibrosis].

A S Brandt1,2,3,4, S Kukuk5,6,7,8, N M Dreger5,6,7,8, E Müller5,6,7,8, S Roth5,6,7,8.   

Abstract

Retroperitoneal fibrosis (RPF) is a rare chronic inflammatory disease of the posterior abdominal cavity. Hydronephrosis due to extrinsic compression of the ureter is the most frequent complication of the disease, which is why patients are often treated by urologists.On the basis of checklists the most important and fundamental facts of diagnosis (symptoms, hydronephrosis, laboratory parameters, diagnostic radiology, histology, renal function and measuring disease activity) and therapy (goals of therapy, medical and surgical therapy) are presented.

Entities:  

Keywords:  Hydronephrosis; Ormond’s disease; Therapy, pharmacological; Therapy, surgical; Ureter obstruction

Mesh:

Year:  2016        PMID: 27168039     DOI: 10.1007/s00120-016-0081-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

1.  Surgery for idiopathic retroperitoneal fibrosis by ureterolysis and ureteric protection with a posterior pre-peritoneal fat flap.

Authors:  Cristóbal García Peñalver; A Tejido Sánchez; A Suárez Charneco; R Díaz González; A Rosino Sánchez; O Leiva Galvis
Journal:  BJU Int       Date:  2002-05       Impact factor: 5.588

2.  Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases.

Authors:  Renzo Marcolongo; Ivan Matteo Tavolini; Francesco Laveder; Moira Busa; Franco Noventa; Pierfrancesco Bassi; Gianpietro Semenzato
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

3.  Ureteral substitution with reconfigured colon: long-term followup.

Authors:  D A Lazica; B Ubrig; A S Brandt; F C von Rundstedt; S Roth
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

4.  Treatment of idiopathic retroperitoneal fibrosis using cyclosporin.

Authors:  A Marzano; A Trapani; N Leone; G C Actis; M Rizzetto
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry.

Authors:  A S Brandt; L Kamper; S Kukuk; P Haage; S Roth
Journal:  J Urol       Date:  2010-12-18       Impact factor: 7.450

6.  Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.

Authors:  Yoh Zen; Manabu Onodera; Dai Inoue; Azusa Kitao; Osamu Matsui; Takahiro Nohara; Mikio Namiki; Satomi Kasashima; Atsuhiro Kawashima; Yasushi Matsumoto; Kazuyoshi Katayanagi; Tetsuya Murata; Shin Ishizawa; Noriko Hosaka; Ken Kuriki; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

7.  Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?

Authors:  Marina N Magrey; M Elaine Husni; Irving Kushner; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2009-05-15

8.  Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series.

Authors:  Jorge Vega; Helmuth Goecke; Héctor Tapia; Eduardo Labarca; Mario Santamarina; Gonzalo Martínez
Journal:  Am J Kidney Dis       Date:  2008-12-31       Impact factor: 8.860

9.  Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil.

Authors:  R D Swartz; A M Lake; W W Roberts; G J Faerber; J S Wolf
Journal:  Clin Nephrol       Date:  2008-04       Impact factor: 0.975

10.  Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.

Authors:  Sven Wenske; Carl A Olsson; Mitchell C Benson
Journal:  Urology       Date:  2013-05-02       Impact factor: 2.649

View more
  2 in total

1.  ["We're going to place a ureteral stent …" : Development and use of the terms stent and splint by German-speaking urologists].

Authors:  Friedrich H Moll; Joachim Leissner; Thorsten Halling
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

Review 2.  [New (and old) aspects of retroperitoneal fibrosis].

Authors:  A S Brandt; N M Dreger; E Müller; S Kukuk; S Roth
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.